News and media
Page 5

Page 5 of 29
Male researcher in a Florey laboratory pipetting a solution into a test tube.

Bacterial infection may impact brain and mental health of future generations

Associate Professor Yugeesh Lankadeva presenting in The Florey's Unlocking hearts and minds public lecture

Unlocking hearts and minds – public lecture

Male researcher with white Florey laboratory coat holding up and inspecting solution in a small tube.

Insomnia medication shows promise in treatment for alcohol use disorder

Two blue Ozempic injections in foreground with a woman holding a packet of the medication in the background.

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

Australian CJD Registry Co-ordinator, Dr Christiane Stehmann
Australian CJD Registry Co-ordinator, Dr Christiane Stehmann

Increased monitoring capacity of deadly prion diseases

Dr Rebecca Nisbet
Dr Rebecca Nisbet

Florey researchers unlock how to use mRNA to target Alzheimer’s disease

Professor David Finkelstein
Professor David Finkelstein

Identifying the early signs of Parkinson’s disease

Supplied workplace

Epilepsy researchers call for more holistic management of the condition after study reveals gaps

The Hon Gabrielle Upton
The Hon Gabrielle Upton

The Hon Gabrielle Upton joins The Florey Board

Dr Pratishtha Chatterjee
Dr Pratishtha Chatterjee

Saving dementia patients from invasive spinal taps

Associate Professor Jess Nithianantharajah, head of the Florey Department of Neuroscience and Mental Health.

Associate Professor Jess Nithianantharajah to lead the Florey Department of Neuroscience and Mental Health

Dr Chaitra Chandrashekar
Dr Chaitra Chandrashekar

Florey discovery could help reduce global shortage of diabetes and weight loss drug semaglutide

Connect with us

Read articles written by our neuroscience experts on The Conversation.

Media enquiries

Kathryn Powley – Media and Communications Manager
P: +61 456 666 271
E: [email protected]

Georgia Brown – Head of Communications and Engagement
P: +61 431 113 346
E: [email protected]

Social media